LDOS

TentativeAI Memo

Leidos

As of 2026-09-05/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-05 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

high-coverage report lacks a dated company-specific catalyst beyond generic cadence; peer set is too generic or lacks enough direct operating comparators

Action

—

Confidence

medium

Horizon

—

Key catalyst

Q2 FY2026 beat and raised guidance • 2026-08-04

Base target: $152 / p=50% prob

Biggest risk

The deterministic prior remains negative across 5- to 120-day horizons. Margin compression, Managed Healthcare contract uncertainty, fixed-price exposure, insourcing risk, and integration or restructuring costs could offset revenue momentum. No post-print analyst estimate or target revisions were available in the packet.

Invalidation

Break below $118 or thesis failure.

What would change my mind?

The Q2 print showed solid revenue growth, strong cash generation, contract awards, and improved full-year guidance. The newly announced Army cyber contract adds a dated company-specific validation of the Cyber growth pillar, while Defense Tech, Energy Infrastructure, and backlog conversion provide further upside if awards translate into profitable production. [#SEC-8K-2026-08-04] [#IR-2026-08-24]

Research note

Recommendation

—

Confidence

medium

As of

2026-09-05

Base target

$152

p=50%

Bull target

$170

p=25%

Bear target

$118

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Recent director open-market selling
Margin and Managed Healthcare execution risk
$301 million five-year Army cyber-defense contract execution

BearKey bullets

Adjusted EBITDA and net income margins declined year over year.
[#SEC-8K-2026-08-04]
Fixed-price contract mix, program execution, acquisition integration, the pending Analogic joint venture, and restructuring costs create execution risk.

WatchKey bullets

Q2 FY2026 beat and raised guidance

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $152 (p=50%)

Target spread vs base: +12% / -22%

Scenario probabilities

Bull Target: $170 (p=25%)Base Target: $152 (p=50%)Bear Target: $118 (p=25%)

Commentary

Recent company IR releases add positive, dated contract evidence, but the packet lacks quantified market-reaction attribution, post-print analyst revisions, social coverage, and other sentiment indicators. The deterministic prior remains negative, and the company-specific contract upside is not yet linked to disclosed revenue or margin timing. Monitoring remains preferable to aggressive positioning.

As of 2026-09-05 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Recent director open-market selling
Margin and Managed Healthcare execution risk
$301 million five-year Army cyber-defense contract execution
Defense-tech bookings and backlog conversion

Scenarios

Bull Target (Scenario probability)

$170 / p=25% prob

Base Target (Scenario probability)

$152 / p=50% prob

Bear Target (Scenario probability)

$118 / p=25% prob

Analysis 2026-09-05 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-08-04
Q2 FY2026 beat and raised guidance
Leidos reported Q2 revenue of $4.6 billion, adjusted EPS of $3.26, operating cash flow of $793 million, and free cash flow of $761 million. Management enhanced full-year revenue, earnings, and cash guidance. [#SEC-8K-2026-08-04]
Prob 100.00% • Move 0.00% • Priced-in 95.00%

Short-term Catalysts

Next few weeks

Recent director open-market selling
2026-09-02
Two directors reported open-market sales in August and September 2026. This is a sentiment risk only and does not provide evidence about operating performance. [#SEC-FORM4-2026-08-13] [#SEC-FORM4-2026-09-02]
Prob 50% • Move -3% • Priced-in 70%
Margin and Managed Healthcare execution risk
2026-12-04
Adjusted EBITDA margin declined to 13.8% from 15.2% year over year, while net income margin declined to 7.8% from 9.2%. Stored Q2 call context also flags Managed Healthcare contract uncertainty and possible insourcing pressure. [#SEC-8K-2026-08-04] [#PR-EARNINGS-2026-08-13]
Prob 60% • Move -12% • Priced-in 45%

Long-term Catalysts

Months to a year

$301 million five-year Army cyber-defense contract execution
2027-09-05
Leidos announced a five-year, $301 million U.S. Army contract to provide around-the-clock cyber operations and new capabilities for military networks. The award provides dated support for the Cyber growth pillar, although revenue timing and margin contribution were not disclosed. [#IR-2026-08-24]
Prob 65% • Move 5% • Priced-in 55%
Defense-tech bookings and backlog conversion
2027-09-05
Management reported $5 billion of contract awards and identified Defense Tech, Energy Infrastructure, and Cyber as growth pillars. Backlog conversion remains a forward upside path, but timing and margin realization are uncertain. [#SEC-8K-2026-08-04]
Prob 55% • Move 12% • Priced-in 65%

Risks

Adjusted EBITDA and net income margins declined year over year. [#SEC-8K-2026-08-04]
Fixed-price contract mix, program execution, acquisition integration, the pending Analogic joint venture, and restructuring costs create execution risk. [#SEC-8K-2026-08-04]
Managed Healthcare contract changes, incentive-payment suspensions, and potential government insourcing may pressure growth or margins. [#PR-EARNINGS-2026-08-13]
Post-print analyst revisions, target changes, and quantified market-reaction attribution remain unavailable.
Recent director open-market sales may weigh on sentiment but are not evidence of operating deterioration. [#SEC-FORM4-2026-08-13] [#SEC-FORM4-2026-09-02]

Peers

Symbol	Summary
SAIC	Direct operating comparator in government technology integration across defense, intelligence, civilian agencies, engineering, IT, and mission solutions; no relative valuation metrics are available. [#IR-SAIC-2026-09-05]
CACI	Direct operating comparator with defense, intelligence, federal civilian, cybersecurity, and mission-technology exposure; no relative valuation metrics are available. [#IR-CACI-2026-09-05]
BAH	Direct-ish government technology and national-security services comparator with defense, intelligence, civil, and advanced-technology exposure; no relative valuation metrics are available. [#IR-BAH-2026-09-05]
J	Broader same-sector services reference with some overlap, but less direct government-defense comparability and no comparative metrics.
BR	Same-sector market-cap reference with limited business-model overlap; retained only as a broad valuation reference.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-05

Loading AI feed…

Symbol

Summary

SAIC

Direct operating comparator in government technology integration across defense, intelligence, civilian agencies, engineering, IT, and mission solutions; no relative valuation metrics are available. [#IR-SAIC-2026-09-05]

CACI

Direct operating comparator with defense, intelligence, federal civilian, cybersecurity, and mission-technology exposure; no relative valuation metrics are available. [#IR-CACI-2026-09-05]

BAH

Direct-ish government technology and national-security services comparator with defense, intelligence, civil, and advanced-technology exposure; no relative valuation metrics are available. [#IR-BAH-2026-09-05]

Broader same-sector services reference with some overlap, but less direct government-defense comparability and no comparative metrics.

Same-sector market-cap reference with limited business-model overlap; retained only as a broad valuation reference.